References

A retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary disease

10.1097/jom.0b013e31802db55f · 2007 · External reference

The epidemiology and economics of chronic obstructive pulmonary disease

10.1513/pats.200701-001fm · 2007 · External reference

The natural history of chronic obstructive pulmonary disease

10.1183/09031936.06.00024605 · 2006 · External reference

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

10.1016/s0140-6736(96)07495-8 · 1997 · External reference

Infection as a comorbidity of COPD

10.1183/09031936.00081409 · 2010 · External reference

Infection in the pathogenesis and course of chronic obstructive pulmonary disease

10.1056/nejmra0800353 · 2008 · External reference

Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease

10.1001/archinte.165.8.891 · 2005 · External reference

Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis

10.1164/ajrccm.164.11.2104093 · 2001 · External reference

Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease

10.1164/rccm.200403-354oc · 2004 · External reference

Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease

10.1164/rccm.200509-1525oc · 2006 · External reference

Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD

10.1183/09031936.04.00056804 · 2004 · External reference

Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic Haemophilus influenzae airway infection: comparison with noninfected patients with chronic obstructive pulmonary disease

10.1164/ajrccm.162.3.9908103 · 2000 · External reference

Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease

10.1183/09031936.99.14510159 · 1999 · External reference

Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease

10.1165/rcmb.2004-0131oc · 2004 · External reference

Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD

10.1136/thx.2003.019349 · 2004 · External reference

Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema

10.1136/thorax.57.5.405 · 2002 · External reference

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease

10.1056/nejmoa012561 · 2002 · External reference

Pseudomonas aeruginosa in chronic obstructive pulmonary disease

10.1164/rccm.200709-1413oc · 2008 · External reference

Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response

10.1164/rccm.200412-1747oc · 2005 · External reference

Antibiotic resistance in sputum isolates of Streptococcus pneumoniae in chronic obstructive pulmonary disease is related to antibiotic exposure

10.3109/15412555.2010.510162 · 2010 · External reference

The Breathlessness, Cough, and Sputum Scale: the development of empirically based guidelines for interpretation

10.1378/chest.124.6.2182 · 2003 · External reference

Unresolved reference

2003 · External reference

Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation

10.1164/rccm.201006-0833oc · 2011 · External reference

Clinical diaries in COPD: compliance and utility in predicting acute exacerbations

2012 · External reference

Report from a workshop on multianalyte microsphere assays

10.1002/cyto.10140 · 2002 · External reference

Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort

10.1164/rccm.200708-1290oc · 2008 · External reference

Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year

10.1183/09031936.00079409 · 2010 · External reference

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

10.1136/thorax.57.10.847 · 2002 · External reference

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

10.1164/ajrccm.164.9.2105011 · 2001 · External reference

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease

10.1164/ajrccm.157.5.9709032 · 1998 · External reference

Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease

10.1164/rccm.200708-1234oc · 2008 · External reference

Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPD

2005 · External reference

The costs of exacerbations in chronic obstructive pulmonary disease (COPD)

10.1053/rmed.2002.1334 · 2002 · External reference

Effect of bronchial colonisation on airway and systemic inflammation in stable COPD

10.3109/15412555.2011.636407 · 2012 · External reference

Variability and effects of bronchial colonisation in patients with moderate COPD

10.1183/09031936.00126808 · 2010 · External reference

Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils

10.1172/jci114265 · 1989 · External reference

Interleukin-8 induces neutrophil transendothelial migration

1991 · External reference

Evaluation of real-time PCR for the detection and quantification of bacteria in chronic obstructive pulmonary disease

10.1111/j.1574-695x.2007.00241.x · 2007 · External reference

Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD

10.1136/thoraxjnl-2012-201924 · 2012 · External reference

Chlamydophila pneumoniae infection and COPD: more evidence for lack of evidence?

10.1016/j.ejim.2009.05.006 · 2009 · External reference

Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case–control study

10.1136/thorax.58.1.37 · 2003 · External reference

Azithromycin for prevention of exacerbations of COPD

10.1056/nejmoa1104623 · 2011 · External reference

Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

10.1186/1465-9921-11-10 · 2010 · External reference